Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (56)
Débora S.B. Rêgo, Michele Longoni Calió, Renato Filev, Luiz E. Mello & Ana T.F.S. Leslie. (2023) Long-term Effects of Cannabidiol and/or Fentanyl Exposure in Rats Submitted to Neonatal Pain. The Journal of Pain.
Crossref
Crossref
Xavier Maia Mariano, Luana Caroline de Assis Ferreira, Camila Megale Almeida-Leite, Célio José de Castro Junior & Maria Elena de Lima. (2023) PnPP-15, a Synthetic Peptide Derived from a Toxin from Phoneutria nigriventer Spider Venom, Alleviates Diabetic Neuropathic Pain and Acts Synergistically with Pregabalin in Mice. Toxins 15:9, pages 560.
Crossref
Crossref
Ani Gasparyan, Francisco Navarrete, Daniela Navarro & Jorge Manzanares. (2023) Cannabidiol regulates behavioral and brain alterations induced by spontaneous alcohol withdrawal. Neuropharmacology 233, pages 109549.
Crossref
Crossref
Yoshinori Takemura, Yuka Sudo, Tomoya Saeki, Shinji Kurata, Tsutomu Suzuki, Tomohisa Mori & Yasuhito Uezono. (2022) Involvement of spinal G-protein inwardly rectifying potassium (GIRK) channels in the enhanced antinociceptive effects of the activation of both μ-opioid and cannabinoid CB1 receptors. Journal of Pharmacological Sciences 149:3, pages 85-92.
Crossref
Crossref
Norikazu Kiguchi & Mei-Chuan Ko. 2022. Behavioral Pharmacology of Drug Abuse: Current Status. Behavioral Pharmacology of Drug Abuse: Current Status
335
371
.
Massroor Pourcyrous, Mohamad T. Elabiad, Divya Rana, Kan P. Gaston, Linda DeBaer & Ramasubbareddy Dhanireddy. (2020) Racial differences in opioid withdrawal syndrome among neonates with intrauterine opioid exposure. Pediatric Research 90:2, pages 459-463.
Crossref
Crossref
Joseph B O'Brien & David L Roman. (2021) Novel treatments for chronic pain: moving beyond opioids. Translational Research 234, pages 1-19.
Crossref
Crossref
Udita Datta, Leslie K. Kelley, Jason W. Middleton & Nicholas W. Gilpin. (2020) Positive allosteric modulation of the cannabinoid type-1 receptor (CB1R) in periaqueductal gray (PAG) antagonizes anti-nociceptive and cellular effects of a mu-opioid receptor agonist in morphine-withdrawn rats. Psychopharmacology 237:12, pages 3729-3739.
Crossref
Crossref
Jennifer D Meeker, Eugenia Ayrian & Edward R Mariano. (2020) Daring discourse – no: cannabinoids should not be used for acute postoperative pain management. Regional Anesthesia & Pain Medicine 45:7, pages 520-523.
Crossref
Crossref
Shanna Babalonis & Sharon L. Walsh. (2020) Therapeutic potential of opioid/cannabinoid combinations in humans: Review of the evidence. European Neuropsychopharmacology 36, pages 206-216.
Crossref
Crossref
Khadijeh Alsadat Sharifi, Ameneh Rezayof, Sakineh Alijanpour & Mohammad-Reza Zarrindast. (2020) GABA-cannabinoid interplays in the dorsal hippocampus and basolateral amygdala mediate morphine-induced amnesia. Brain Research Bulletin 157, pages 61-68.
Crossref
Crossref
Stephanie Lake, Zach Walsh, Thomas Kerr, Ziva D. Cooper, Jane Buxton, Evan Wood, Mark A. Ware & M. J. Milloy. (2019) Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: A longitudinal analysis. PLOS Medicine 16:11, pages e1002967.
Crossref
Crossref
Jun-Xu Li. (2019) Combining opioids and non-opioids for pain management: Current status. Neuropharmacology 158, pages 107619.
Crossref
Crossref
David Rice, Jo Nijs, Eva Kosek, Timothy Wideman, Monika I Hasenbring, Kelli Koltyn, Thomas Graven-Nielsen & Andrea Polli. (2019) Exercise-Induced Hypoalgesia in Pain-Free and Chronic Pain Populations: State of the Art and Future Directions. The Journal of Pain 20:11, pages 1249-1266.
Crossref
Crossref
Shanna Babalonis, Michelle R. Lofwall, Paul A. Sloan, Paul A. Nuzzo, Laura C. Fanucchi & Sharon L. Walsh. (2019) Cannabinoid modulation of opioid analgesia and subjective drug effects in healthy humans. Psychopharmacology 236:11, pages 3341-3352.
Crossref
Crossref
Xiaohong Chen, Alan Cowan, Saadet Inan, Ellen B. Geller, Joseph J. Meissler, Scott M. Rawls, Ronald J. Tallarida, Christopher S. Tallarida, Mia N. Watson, Martin W. Adler & Toby K. Eisenstein. (2019)
Opioid‐sparing effects of cannabinoids on morphine analgesia: participation of CB
1
and CB
2
receptors
. British Journal of Pharmacology 176:17, pages 3378-3389.
Crossref
Crossref
Stephen Bruehl, John W. Burns, Amanda Morgan, Kelli Koltyn, Rajnish Gupta, Asokumar Buvanendran, David Edwards, Melissa Chont, Philip J. Kingsley, Larry Marnett, Amanda Stone & Sachin Patel. (2018) The association between endogenous opioid function and morphine responsiveness: a moderating role for endocannabinoids. Pain 160:3, pages 676-687.
Crossref
Crossref
Luiz Fabio Dimov, Elaine Flamia Toniolo, Heloísa Alonso-Matielo, Daniel Ciampi de Andrade, Luis Garcia-Larrea, Gerson Ballester, Manoel Jacobsen Teixeira & Camila Squarzoni Dale. (2018) Electrical stimulation of the insular cortex as a novel target for the relief of refractory pain: An experimental approach in rodents. Behavioural Brain Research 346, pages 86-95.
Crossref
Crossref
Kevin M Crombie, Angelique G Brellenthin, Cecilia J Hillard & Kelli F Koltyn. (2018) Endocannabinoid and Opioid System Interactions in Exercise-Induced Hypoalgesia. Pain Medicine 19:1, pages 118-123.
Crossref
Crossref
. 2018. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin
253
445
.
Melanie B Elliott, Sara J Ward, Mary E Abood, Ronald F Tuma & Jack I Jallo. (2017) Understanding the endocannabinoid system as a modulator of the trigeminal pain response to concussion. Concussion 2:4, pages CNC49.
Crossref
Crossref
Sara González-Rodríguez, Hervé Poras, Luis Menéndez, Ana Lastra, Tanja Ouimet, Marie-Claude Fournié-Zaluski, Bernard P. Roques & Ana Baamonde. (2017) Synergistic combinations of the dual enkephalinase inhibitor PL265 given orally with various analgesic compounds acting on different targets, in a murine model of cancer-induced bone pain. Scandinavian Journal of Pain 14:1, pages 25-38.
Crossref
Crossref
Salvador Sierra, Ivone Gomes & Lakshmi A. Devi. 2017. G-Protein-Coupled Receptor Dimers. G-Protein-Coupled Receptor Dimers
173
206
.
Zi-Long Wang, Jia-Xin Pan, Jing-Jing Song, Hong-Hai Tang, Hong-Ping Yu, Xu-Hui Li, Ning Li, Ting Zhang, Run Zhang, Meng-Na Zhang, Biao Xu, Quan Fang & Rui Wang. (2016) Structure-Based Optimization of Multifunctional Agonists for Opioid and Neuropeptide FF Receptors with Potent Nontolerance Forming Analgesic Activities. Journal of Medicinal Chemistry 59:22, pages 10198-10208.
Crossref
Crossref
R D Holmes, A K Tiwari & J L Kennedy. (2016) Mechanisms of the placebo effect in pain and psychiatric disorders. The Pharmacogenomics Journal 16:6, pages 491-500.
Crossref
Crossref
David R. Maguire & Charles P. France. (2016) Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl. European Journal of Pharmacology 784, pages 199-206.
Crossref
Crossref
Michelle R. Lofwall, Shanna Babalonis, Paul A. Nuzzo, Samy Claude Elayi & Sharon L. Walsh. (2016) Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans. Drug and Alcohol Dependence 164, pages 143-150.
Crossref
Crossref
Andrea I. Loewendorf, Anna Matynia, Hakob Saribekyan, Noah Gross, Marie Csete & Mike Harrington. (2016) Roads Less Traveled: Sexual Dimorphism and Mast Cell Contributions to Migraine Pathology. Frontiers in Immunology 7.
Crossref
Crossref
David R. Maguire & Charles P. France. (2016) Additive antinociceptive effects of mixtures of the κ-opioid receptor agonist spiradoline and the cannabinoid receptor agonist CP55940 in rats. Behavioural Pharmacology 27:1, pages 69-72.
Crossref
Crossref
Crystal J. Jicha, Michelle R. Lofwall, Paul A. Nuzzo, Shanna Babalonis, Samy Claude Elayi & Sharon L. Walsh. (2015) Safety of oral dronabinol during opioid withdrawal in humans. Drug and Alcohol Dependence 157, pages 179-183.
Crossref
Crossref
. 2015. Arzneimitteltherapie in der Palliativmedizin. Arzneimitteltherapie in der Palliativmedizin
229
415
.
Robert E. Blair, Laxmikant S. Deshpande & Robert J. DeLorenzo. 2015. Cannabinoids in Neurologic and Mental Disease. Cannabinoids in Neurologic and Mental Disease
125
172
.
Daniel F. Martins, Rômulo N. Brito, Juliana Stramosk, Ana P. Batisti, Fernanda Madeira, Bruna L. Turnes, Leidiane Mazzardo-Martins, Adair R.S. Santos & Anna P. Piovezan. (2015) Peripheral neurobiologic mechanisms of antiallodynic effect of warm water immersion therapy on persistent inflammatory pain. Journal of Neuroscience Research 93:1, pages 157-166.
Crossref
Crossref
David R. Maguire & Charles P. France. (2014)
Impact of Efficacy at the
μ
-Opioid Receptor on Antinociceptive Effects of Combinations of
μ
-Opioid Receptor Agonists and Cannabinoid Receptor Agonists
. Journal of Pharmacology and Experimental Therapeutics 351:2, pages 383-389.
Crossref
Crossref
M Peciña, M Martínez-Jauand, C Hodgkinson, C S Stohler, D Goldman & J K Zubieta. (2013) FAAH selectively influences placebo effects. Molecular Psychiatry 19:3, pages 385-391.
Crossref
Crossref
J. Desroches, J.-F. Bouchard, L. Gendron & P. Beaulieu. (2014) Involvement of cannabinoid receptors in peripheral and spinal morphine analgesia. Neuroscience 261, pages 23-42.
Crossref
Crossref
F C Machado, V O Zambelli, A C O Fernandes, A S Heimann, Y Cury & G Picolo. (2014) Peripheral interactions between cannabinoid and opioid systems contribute to the antinociceptive effect of crotalphine. British Journal of Pharmacology 171:4, pages 961-972.
Crossref
Crossref
Alfred N Fonteh, Janice M Pogoda, Rainbow Chung, Robert P Cowan & Michael G Harrington. (2013) Phospholipase C activity increases in cerebrospinal fluid from migraineurs in proportion to the number of comorbid conditions: a case–control study. The Journal of Headache and Pain 14:1.
Crossref
Crossref
Gerburg Keilhoff, Helmut Schröder, Brigitte Peters & Axel Becker. (2013) Time-course of neuropathic pain in mice deficient in neuronal or inducible nitric oxide synthase. Neuroscience Research 77:4, pages 215-221.
Crossref
Crossref
Amer H. Tarawneh, Francisco León, Mohamed M. Radwan, Xiaoning Wang, Olivia R. Dale, Afeef S. Husni, Luiz H. Rosa & Stephen J. Cutler. (2013)
Fatty Acids with in Vitro Binding Affinity for Human Opioid Receptors from the Fungus
Emericella nidulans
. Journal of Agricultural and Food Chemistry 61:44, pages 10476-10480.
Crossref
Crossref
J.L. Scavone, R.C. Sterling & E.J. Van Bockstaele. (2013) Cannabinoid and opioid interactions: Implications for opiate dependence and withdrawal. Neuroscience 248, pages 637-654.
Crossref
Crossref
Paul Howard, Robert Twycross, John Shuster, Mary Mihalyo & Andrew Wilcock. (2013) Cannabinoids. Journal of Pain and Symptom Management 46:1, pages 142-149.
Crossref
Crossref
David R. Maguire, Wenjuan Yang & Charles P. France. (2013)
Interactions between
μ
-Opioid Receptor Agonists and Cannabinoid Receptor Agonists in Rhesus Monkeys: Antinociception, Drug Discrimination, and Drug Self-Administration
. Journal of Pharmacology and Experimental Therapeutics 345:3, pages 354-362.
Crossref
Crossref
Fabrizio Benedetti, Wilma Thoen, Catherine Blanchard, Sergio Vighetti & Claudia Arduino. (2013) Pain as a reward: Changing the meaning of pain from negative to positive co-activates opioid and cannabinoid systems. Pain 154:3, pages 361-367.
Crossref
Crossref
Ittai Bushlin, Achla Gupta, Steven D. Stockton, Lydia K. Miller & Lakshmi A. Devi. (2012) Dimerization with Cannabinoid Receptors Allosterically Modulates Delta Opioid Receptor Activity during Neuropathic Pain. PLoS ONE 7:12, pages e49789.
Crossref
Crossref
Roger G. Pertwee. (2012) Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities. Philosophical Transactions of the Royal Society B: Biological Sciences 367:1607, pages 3353-3363.
Crossref
Crossref
Laurence L. Miller, Mitchell J. Picker, Michael D. Umberger, Karl T. Schmidt & Linda A. Dykstra. (2012) Effects of Alterations in Cannabinoid Signaling, Alone and in Combination with Morphine, on Pain-Elicited and Pain-Suppressed Behavior in Mice. Journal of Pharmacology and Experimental Therapeutics 342:1, pages 177-187.
Crossref
Crossref
A.R. Wilson-Poe, M.M. Morgan, S.A. Aicher & D.M. Hegarty. (2012) Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal gray. Neuroscience 213, pages 191-200.
Crossref
Crossref
Russell K. Portenoy, Elena Doina Ganae-Motan, Silvia Allende, Ronald Yanagihara, Lauren Shaiova, Sharon Weinstein, Robert McQuade, Stephen Wright & Marie T. Fallon. (2012) Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial. The Journal of Pain 13:5, pages 438-449.
Crossref
Crossref
Bernard P. Roques, Marie-Claude Fournié-Zaluski & Michel Wurm. (2012) Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain. Nature Reviews Drug Discovery 11:4, pages 292-310.
Crossref
Crossref
Mark Collen. (2012) Prescribing cannabis for harm reduction. Harm Reduction Journal 9:1, pages 1.
Crossref
Crossref
Jiangtao Gao, Francisco León, Mohamed M. Radwan, Olivia R. Dale, Afeef S. Husni, Susan P. Manly, Shari Lupien, Xiaoning Wang, Robert A. Hill, Frank M. Dugan, Horace G. Cutler & Stephen J. Cutler. (2011)
Benzyl Derivatives with
in Vitro
Binding Affinity for Human Opioid and Cannabinoid Receptors from the Fungus
Eurotium repens
. Journal of Natural Products 74:7, pages 1636-1639.
Crossref
Crossref
Elvan Kut, Victor Candia, Jan von Overbeck, Judit Pok, Daniel Fink & Gerd Folkers. (2011) Pleasure-Related Analgesia Activates Opioid-Insensitive Circuits. The Journal of Neuroscience 31:11, pages 4148-4153.
Crossref
Crossref
Jonathon C. Arnold, Robert A. Dielenberg & Iain S. McGregor. (2010) Cannabinoids increase conditioned ultrasonic vocalisations and cat odour avoidance in rats: Strain differences in drug-induced anxiety. Life Sciences 87:17-18, pages 572-578.
Crossref
Crossref
Rosaria Greco, Valeria Gasperi, Mauro Maccarrone & Cristina Tassorelli. (2010) The endocannabinoid system and migraine. Experimental Neurology 224:1, pages 85-91.
Crossref
Crossref
Tricia H Smith, Laura J Sim‐Selley & Dana E Selley. (2010)
Cannabinoid CB
1
receptor‐interacting proteins: novel targets for central nervous system drug discovery?
. British Journal of Pharmacology 160:3, pages 454-466.
Crossref
Crossref